Table 1. Result from two-way ANOVA of analysed APM components.
APM component | GCLs | Experimental time points | Interaction |
---|---|---|---|
ERAP1 | 1.33*10−15 | 4.94*10−2 | 5.70*10−2 |
LMP2 | 2.83*10−11 | 5.31*10−8 | 4.00*10−4 |
ERp57 | 2.13*10−10 | 3.72*10−6 | 6.61*10−4 |
Tapasin | 2.68*10−10 | 2.17*10−7 | 2.84*10−2 |
β2m | 8.74*10−10 | 8.10*10−6 | 3.00*10−1 |
LMP7 | 2.18*10−9 | 7.90*10−7 | 1.69*10−5 |
HLA-I HC | 3.27*10−8 | 2.36*10−5 | 5.23*10−3 |
TAP1 | 5.01*10−7 | 1.77*10−3 | 2.79*10−4 |
ERAP2 | 4.66*10−6 | 4.66*10−1 | 5.92*10−5 |
TAP2 | 3.21*10−5 | 2.42*10−3 | 2.65*10−2 |
Calnexin | 1.24*10−3 | 1.51*10−3 | 5.49*10−3 |
Calreticulin | 2.65*10−3 | 1.13*10−3 | 5.14*10−1 |
β-COPI | 1.94*10−2 | 3.27*10−2 | 1.03*10−2 |
BAP31 | 5.92*10−1 | 2.76*10−3 | 9.33*10−1 |
Abbreviations: ANOVA=analysis of variance; APM=antigen-processing machinery; β2m=β2-microglobulin; GCL=glioma cell line; HC=heavy chain.
All the reported numbers are P-values.